vrinda sharma

China wanted to become a ‘high-tech superpower’. Did it succeed?

China wanted to become a ‘high-tech superpower’. Did it succeed?

A decade ago the Chinese government announced plans to transform the country from “a low-cost manufacturing base into a high-tech superpower”. Did it work? A decade ago the Chinese government announced plans to transform the country from “a low-cost manufacturing base into a high-tech superpower”. Did it work? Economy, World Politics, Trade, Science and Technology, Defence and…

Read More

JSW Group to invest $35 billion in Maharashtra to expand in EV and green energy sectors – Moneycontrol

JSW Group to invest $35 billion in Maharashtra to expand in EV and green energy sectors  Moneycontrol World Economic Forum Meet Live Updates: D Fadnavis, Chandrababu Naidu In Davos  NDTV World Economic Forum 2025 Day 2 highlights: Maharashtra signs MoUs worth ₹4.99 lakh crore  The Hindu Maharashtra CM Devendra Fadnavis meets WEF founder, State’s Pavilion set for record…

Read More

Donald Trump rewrites history with January 6 pardons – Hindustan Times

Donald Trump rewrites history with January 6 pardons  Hindustan Times In Historic Move, Trump Pardons Over 1,500 January 6 Defendants: ‘A Grave National Injustice’  Zee News Capitol riot leaders Tarrio and Rhodes released from prison  BBC.com Siblings, accused in January 6 riots, become first to walk out of jail, after Donald Trump’s pardon order  The Times of India 18…

Read More

Nifty, Sensex sink to seven-month low amid jitters over Trump’s swearing-in – Mint

Nifty, Sensex sink to seven-month low amid jitters over Trump’s swearing-in  Mint Ahead of Market: 10 things that will decide stock market action on Wednesday  The Economic Times Stock market crash today: BSE Sensex ends over 1,200 points down; Nifty50 near 23,050 – top reasons for b  The Times of India Market Trumped! Sensex nosedives 1,235 points, investors…

Read More

GLP-1 Medications: A dual impact on health benefits and side effects – The Economic Times

GLP-1 Medications: A dual impact on health benefits and side effects  The Economic Times Mapping the effectiveness and risks of GLP-1 receptor agonists  Nature.com Diabetes and Obesity Drugs Study Points to Effectiveness in Curbing Addictions  Bloomberg Not just weight loss, GLP-1 drugs like Ozempic can help with 175 conditions; says groundbreaking study  The Times of India Weight-loss jabs linked…

Read More